30 January 2025
30 January 2025
Prioritising US health, Trump has already frozen the supply of HIV and malaria medication aid to endemic countries.
The deal includes an upfront payment of $250m, with the potential for an additional $752.5m in milestone payments.
Enhertu is projected to reach $13.9bn in sales by 2030, according to GlobalData’s Pharma Intelligence Center.
The partnership integrates Leveragen’s Singularity Sapiens Mouse platform with the T-cell engineering expertise of Moonlight Bio.
The partnership is jointly funded by the European Regional Development Fund.
Under the stewardship of Jessica Ballinger, the company completed a pivotal efficacy study for LYN-005.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
